• Explore /
  • Poster
  • / Safety and feasibility of esophagectomy following neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: Analysis of two phase 2 clinical trials.

Safety and feasibility of esophagectomy following neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: Analysis of two phase 2 clinical trials.

Abstract Poster

Authors

null

dijian shen

Zhejiang Cancer Hospital (Zhejiang Cancer Center), Hangzhou, Zhejiang, China

dijian shen , Runzhe Chen , Yongling Ji , Qixun Chen , Ming Chen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Local-Regional Disease

Clinical Trial Registration Number

NCT03940001;NCT04506138

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 4070)

DOI

10.1200/JCO.2024.42.16_suppl.4070

Abstract #

4070

Poster Bd #

50

Abstract Disclosures

Similar Posters

First Author: Manabu Muto

First Author: Edwin P Hui

First Author: Marcia Hall

Poster

2020 Gastrointestinal Cancers Symposium

First-line chemotherapy versus chemoradiation for resectable distal esophageal adenocarcinoma.

First-line chemotherapy versus chemoradiation for resectable distal esophageal adenocarcinoma.

First Author: Susanna W. L. de Geus